Inhibikase Therapeutics ( (IKT)) has shared an announcement. On December 19, 2025, Inhibikase Therapeutics, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to ...

According to the press release statement, distributions will no longer be made under previous ATM program prospectus supplements, including the one dated May 2, 2025. Sprott Asset Management LP, a ...

Strive (ASST), a publicly traded bitcoin BTC $89,524.02 treasury and asset-management company, said it arranged a $500 million at-the-market offering (ATM) for its Variable Rate Series A Perpetual ...

Oklo Inc. (OKLO), a pre-revenue advanced fission developer, continues to scale toward commercial operations with sizable capital requirements. To meet this need, the company recently launched a ...